PNC Infra to divest stake in Ghaziabad Aligarh Eway
PNC Infra to divest stake in Ghaziabad Aligarh Eway

PNC Infra to divest stake in Ghaziabad Aligarh Eway

Nidhi Jani Article rating: 5.0

PNC Infratech has entered into a share purchase agreement with Cube Highways and Infrastructure for sale of its entire stake, i.e. 2,93,24,000 equity shares, representing 15.12 per cent of the total shareholding in Ghaziabad Aligarh Expressway, an associate of PNC Infratech.

A welcome move from Franklin Templeton MF
A welcome move from Franklin Templeton MF

A welcome move from Franklin Templeton MF

Henil Shah Article rating: 3.5

Franklin Templeton MF abolishes exit load on a switch from regular plan to direct plan. What does it mean to you? Let’s find out.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on May 06, 2019 opened gap down. BSE Sensex is trading at 38,657.36 down by 305.90 points and the Nifty is trading at 11,614.50, down by 97.75 points. 

Alembic Pharma gains on EIR for JV firm
Alembic Pharma gains on EIR for JV firm

Alembic Pharma gains on EIR for JV firm

Nidhi Jani Article rating: 5.0

This is for the inspection carried out by them at Aleor Dermaceuticals’ formulation facility at Karakhadi, Gujarat during the period from February 4, 2019 to February 8, 2019.

Dr Reddy introduces Testosterone gel
Dr Reddy introduces Testosterone gel

Dr Reddy introduces Testosterone gel

Nidhi Jani Article rating: 5.0

Dr. Reddy's Laboratories informed the bourses that it has launched Testosterone Gel 1.62 per cent, a therapeutic equivalent generic version of AndroGel (testosterone gel) 1.62 per cent, approved by USFDA.

ITC to raise market share in fruit juice segment
ITC to raise market share in fruit juice segment

ITC to raise market share in fruit juice segment

Nidhi Jani Article rating: 3.2

Eyeing a bigger market share in the packaged fruit and juice segment, ITC has launched three new variants under its product ‘B Natural’, which is into fruit beverages.

Q4FY19: Morepen Labs profit jumps 125 per cent
Q4FY19: Morepen Labs profit jumps 125 per cent

Q4FY19: Morepen Labs profit jumps 125 per cent

Advait Dharmadhikari Article rating: 3.3

Morepen Labs reported a steep 125 per cent rise in its net profit at Rs. 9.22 crore from Rs. 4.11 crore in YoY and a 31 per cent rise in its total revenue at Rs. 207.1 crore in the quarter ended March 2019 as against Rs. 158.34 crore.

RSS
First31113112311331143116311831193120Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR